Skip to main navigation Skip to search Skip to main content

Obesity and kidney disease: Beyond the hyperfiltration

  • A. Mascali
  • , O. Franzese
  • , S. Nisticò*
  • , Salvatore Nistico'*
  • , U. Campia
  • , D. Lauro
  • , Carmine Cardillo
  • , N. Di Daniele
  • , M. Tesauro
  • *Corresponding author

Research output: Contribution to journalArticlepeer-review

12   Link opens in a new tab Citations (SciVal)

Abstract

In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage.
Original languageEnglish
Pages (from-to)354-363
Number of pages10
JournalInternational Journal of Immunopathology and Pharmacology
Volume29
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Immunology
  • Immunology and Allergy
  • Pharmacology
  • hyperfiltration
  • kidney disease
  • obesity

Fingerprint

Dive into the research topics of 'Obesity and kidney disease: Beyond the hyperfiltration'. Together they form a unique fingerprint.

Cite this